$200,000 of ACCENDRA HEALTH INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. FY 2027 Appropriations. Issues related to patient access to home medical equipment and related reimbursement."
You can find more data on corporate lobbying on Quiver Quantitative.
ACH Hedge Fund Activity
We have seen 61 institutional investors add shares of ACH stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,888,058 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,877,158
- CITADEL ADVISORS LLC removed 1,386,872 shares (-85.5%) from their portfolio in Q1 2026, for an estimated $3,162,068
- JANE STREET GROUP, LLC removed 1,070,909 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,441,672
- DIMENSIONAL FUND ADVISORS LP removed 966,457 shares (-37.1%) from their portfolio in Q2 2026, for an estimated $3,305,282
- MARSHALL WACE, LLP added 821,575 shares (+46.7%) to their portfolio in Q2 2026, for an estimated $2,809,786
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 747,468 shares (-20.6%) from their portfolio in Q2 2026, for an estimated $2,556,340
- INVENOMIC CAPITAL MANAGEMENT LP removed 556,501 shares (-16.5%) from their portfolio in Q2 2026, for an estimated $1,903,233
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ACH Price Targets
Multiple analysts have issued price targets for $ACH recently. We have seen 3 analysts offer price targets for $ACH in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $6.0 on 05/12/2026
- Daniel Grosslight from Citigroup set a target price of $5.0 on 05/12/2026
- Kevin Caliendo from UBS set a target price of $4.5 on 05/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
